Grifols supplies recombinant antigens from the Core, NS3, NS4 and NS5 regions of the Hepatitis C Virus (HCV) genome. These antigens are currently used in immunoassays that test >60% of the blood donations worldwide as well as clinical testing of patients.
Five HCV antigens are licensed biologics with the FDA.
Companion reagents available: E.coli extract, yeast extract, rHSOD for SOD fusion antigens**
*Antigens in gray are in development
**Many antigens are SOD fusions to increase expression